Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe record history shows an updated revision tag: v3.6.6 replaces the previous v3.6.5, indicating a metadata update to the study record. No substantive study data or content appears to be changed.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA new revision entry is added: v3.6.5, signaling a newer version of the study record and replacing the previous v3.6.4 entry.SummaryDifference0.1%

- Check54 days agoChange DetectedA new platform revision (v3.6.4) is added to the history, while the previous revision (v3.6.3) is removed from the current listing, indicating a minor system update to the history page.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision (v3.6.3) was added to the record history, while the earlier revision (v3.6.2) was removed from the history. This updates the documented versioning of the study record without altering its substantive content.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision tag on the Record History page was updated from v3.6.0 to v3.6.2, signaling a minor version update of the page itself. This change reflects an administrative update rather than a modification to the study data or user-facing content.SummaryDifference0.1%

- Check97 days agoChange DetectedThe history adds 'No longer looking for participants' and 'Revision: v3.6.0', and removes the older 'Revision: v3.5.5'.SummaryDifference0.4%

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.